Works matching DE "COMPLEMENT inhibition"
Results: 715
The Buter/Giaccone Article Reviewed.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 13, p. 1721
- By:
- Publication type:
- Article
Methylating fingers.
- Published in:
- Nature Structural & Molecular Biology, 2012, v. 19, n. 1, p. 8, doi. 10.1038/nsmb.2226
- By:
- Publication type:
- Article
A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations.
- Published in:
- Nature Structural & Molecular Biology, 2011, v. 18, n. 6, p. 721, doi. 10.1038/nsmb.2076
- By:
- Publication type:
- Article
C6-Like and C3-Like Molecules from the Cephalochordate, Amphioxus, Suggest a Cytolytic Complement System in Invertebrates.
- Published in:
- Journal of Molecular Evolution, 2002, v. 54, n. 5, p. 671, doi. 10.1007/s00239-001-0068-z
- By:
- Publication type:
- Article
Serum complement inactivation unveiled prepregnancy donor-specific HLA antibodies leading to postpartum kidney graft loss.
- Published in:
- Transplant International, 2015, v. 28, n. 5, p. 623, doi. 10.1111/tri.12521
- By:
- Publication type:
- Article
Review and Appraisal of Current and Investigational Complement System Inhibitory Therapy for Geographic Atrophy Secondary to Age- related Macular Degeneration.
- Published in:
- touchREVIEWS in Ophthalmology, 2024, v. 18, n. 1, p. 25, doi. 10.17925/usor.2024.18.1.6
- By:
- Publication type:
- Article
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
- Published in:
- Nature Immunology, 2005, v. 6, n. 9, p. 920, doi. 10.1038/ni1235
- By:
- Publication type:
- Article
Aspecte noi de tratament cu terapie biologică în miastenia gravis.
- Published in:
- Farmacist.ro, 2024, v. 219, n. 4, p. 28
- By:
- Publication type:
- Article
Investigation of the Patients with Angioedema who Applied to the Emergency Department.
- Published in:
- Eurasian Journal of Emergency Medicine, 2020, v. 19, n. 4, p. 213, doi. 10.4274/eajem.galenos.2020.00821
- By:
- Publication type:
- Article
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein Microarrays.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1694, doi. 10.3390/vaccines11111694
- By:
- Publication type:
- Article
Immunotherapeutic Targeting of NG2/CSPG4 in Solid Organ Cancers.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071023
- By:
- Publication type:
- Article
The complement inhibitors in COVID-19: future expectations.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2020, v. 24, n. 12, p. 6480
- By:
- Publication type:
- Article
Chronic complement dysregulation drives neuroinflammation after traumatic brain injury: a transcriptomic study.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01226-2
- By:
- Publication type:
- Article
Complement mediates neuroinflammation and cognitive decline at extended chronic time points after traumatic brain injury.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01179-6
- By:
- Publication type:
- Article
Beneficial versus Detrimental Effects of Complement–Microglial Interactions in Alzheimer's Disease.
- Published in:
- Brain Sciences (2076-3425), 2024, v. 14, n. 5, p. 434, doi. 10.3390/brainsci14050434
- By:
- Publication type:
- Article
Effect of Health Status and Heat-Induced Inactivation on the Proteomic Profile of Plasma Rich in Growth Factors Obtained from Donors with Chronic Inflammatory Skin Conditions.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 7, p. 763, doi. 10.3390/biom14070763
- By:
- Publication type:
- Article
The Molecular Mechanisms of Complement Receptor 1—It Is Complicated.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 10, p. 1522, doi. 10.3390/biom13101522
- By:
- Publication type:
- Article
The Role of Clusterin Transporter in the Pathogenesis of Alzheimer's Disease at the Blood–Brain Barrier Interface: A Systematic Review.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 10, p. N.PAG, doi. 10.3390/biom12101452
- By:
- Publication type:
- Article
Recombinant Production of MFHR1, A Novel Synthetic Multitarget Complement Inhibitor, in Moss Bioreactors.
- Published in:
- Frontiers in Plant Science, 2019, p. N.PAG, doi. 10.3389/fpls.2019.00260
- By:
- Publication type:
- Article
Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1128994
- By:
- Publication type:
- Article
In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1180833
- By:
- Publication type:
- Article
Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1203506
- By:
- Publication type:
- Article
C4b-binding protein inhibits particulate- and crystalline-induced NLRP3 inflammasome activation.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1149822
- By:
- Publication type:
- Article
Efficient complement-mediated clearance of immunosuppressed T cells by macrophages.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1183180
- By:
- Publication type:
- Article
Evaluating the comorbidities of age and cigarette smoking on stroke outcomes in the context of anti-complement mitigation strategies.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1161051
- By:
- Publication type:
- Article
The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1180509
- By:
- Publication type:
- Article
The many faces of parasite calreticulin.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1101390
- By:
- Publication type:
- Article
The association between serum complement C3a and severity in patients with community-acquired pneumonia.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2023.1034233
- By:
- Publication type:
- Article
Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoids.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1058763
- By:
- Publication type:
- Article
Complement-targeting therapeutics for ischemiareperfusion injury in transplantation and the potential for ex vivo delivery.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1000172
- By:
- Publication type:
- Article
Complement-targeted therapies in kidney transplantation--insights from preclinical studies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.984090
- By:
- Publication type:
- Article
MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.985766
- By:
- Publication type:
- Article
Simultaneous C5 and CD14 inhibition limits inflammation and organ dysfunction in pig polytrauma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.952267
- By:
- Publication type:
- Article
The role of the complement system in Multiple Sclerosis: A review.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.970486
- By:
- Publication type:
- Article
CipA mediates complement resistance of Acinetobacter baumannii by formation of a factor I-dependent quadripartite assemblage.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.942482
- By:
- Publication type:
- Article
Complement Inhibition in ANCA-Associated Vasculitis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.888816
- By:
- Publication type:
- Article
An Interdisciplinary Diagnostic Approach to Guide Therapy in C3 Glomerulopathy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.826513
- By:
- Publication type:
- Article
The anti-inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load.
- Published in:
- Clinical & Experimental Immunology, 2015, v. 181, n. 3, p. 457, doi. 10.1111/cei.12645
- By:
- Publication type:
- Article
The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein.
- Published in:
- Clinical & Experimental Immunology, 2006, v. 144, n. 2, p. 342, doi. 10.1111/j.1365-2249.2006.03071.x
- By:
- Publication type:
- Article
Increased serum C3 levels in Crry transgenic mice partially abrogates its complement inhibitory effects.
- Published in:
- Clinical & Experimental Immunology, 2004, v. 136, n. 2, p. 194, doi. 10.1111/j.1365-2249.2004.02450.x
- By:
- Publication type:
- Article
Tears contain the complement regulator CD59 as well as decay-accelerating factor (DAF).
- Published in:
- Clinical & Experimental Immunology, 2001, v. 123, n. 2, p. 188, doi. 10.1046/j.1365-2249.2001.01408.x
- By:
- Publication type:
- Article
Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
- Published in:
- Clinical & Experimental Immunology, 1998, v. 113, n. 2, p. 173, doi. 10.1046/j.1365-2249.1998.00581.x
- By:
- Publication type:
- Article
Complement-regulatory protein expression and activation of complement cascade on erythrocytes...
- Published in:
- Clinical & Experimental Immunology, 1998, v. 111, n. 1, p. 102, doi. 10.1046/j.1365-2249.1998.00449.x
- By:
- Publication type:
- Article
Tumour cell killing using chemically engineered antibody constructs specific for tumour cells and the complement inhibitor CD59.
- Published in:
- Clinical & Experimental Immunology, 1997, v. 107, n. 2, p. 364, doi. 10.1111/j.1365-2249.1997.265-ce1156.x
- By:
- Publication type:
- Article
Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection.
- Published in:
- Clinical & Experimental Immunology, 1995, v. 102, n. 3, p. 589
- By:
- Publication type:
- Article
A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement.
- Published in:
- Clinical & Experimental Immunology, 1995, v. 102, n. 3, p. 582
- By:
- Publication type:
- Article
Clinical and Complement Long-Term Follow-Up of a Pediatric Patient with C3 Mutation-Related Atypical Hemolytic Uremic Syndrome.
- Published in:
- Case Reports in Nephrology, 2018, p. 1, doi. 10.1155/2018/3810249
- By:
- Publication type:
- Article
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
- Published in:
- Lupus, 2020, v. 29, n. 12, p. 1571, doi. 10.1177/0961203320950461
- By:
- Publication type:
- Article
C3aR inhibition reduces neurodegeneration in experimental lupus.
- Published in:
- Lupus, 2010, v. 19, n. 1, p. 73, doi. 10.1177/0961203309348978
- By:
- Publication type:
- Article
The Future Use of Complement Inhibitors for the Treatment of Neurological Diseases.
- Published in:
- Drugs, 1998, v. 55, n. 6, p. 739, doi. 10.2165/00003495-199855060-00001
- By:
- Publication type:
- Article